1. Home
  2. GRNQ vs MBIO Comparison

GRNQ vs MBIO Comparison

Compare GRNQ & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.74

Market Cap

12.1M

Sector

Technology

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.12

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
MBIO
Founded
2013
2015
Country
Malaysia
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
4.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GRNQ
MBIO
Price
$1.74
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.7K
96.6K
Earning Date
11-13-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,110,208.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.04
N/A
52 Week Low
$0.84
$0.89
52 Week High
$2.50
$21.95

Technical Indicators

Market Signals
Indicator
GRNQ
MBIO
Relative Strength Index (RSI) 54.78 39.03
Support Level $1.60 $1.05
Resistance Level $1.88 $1.31
Average True Range (ATR) 0.11 0.08
MACD -0.00 -0.01
Stochastic Oscillator 65.00 13.88

Price Performance

Historical Comparison
GRNQ
MBIO

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: